Authors:
Takenaka, K
Yasuda, S
Miyazaki, S
Kurita, T
Sutani, Y
Morii, I
Daikoku, S
Kamakura, S
Nonogi, H
Citation: K. Takenaka et al., Initial experience with nifekalant hydrochloride (MS-551), a novel class III antiarrhythmic agent, in patients with acute extensive infarction and severe ventricular dysfunction, JPN CIRC J, 65(1), 2001, pp. 60-62
Authors:
Kanna, M
Nonogi, H
Sumida, H
Miyazaki, S
Daikoku, S
Morii, I
Yasuda, S
Sutani, Y
Baba, T
Goto, Y
Citation: M. Kanna et al., Usefulness of serum troponin T levels on day three or four in predicting survival after acute myocardial infarction, AM J CARD, 87(3), 2001, pp. 294-297
Authors:
Otsuka, Y
Miyazaki, S
Okumura, H
Yasuda, S
Daikoku, S
Morii, I
Sutani, Y
Goto, Y
Nonogi, H
Citation: Y. Otsuka et al., Abnormal glucose tolerance, not small vessel diameter, is a determinant oflong-term prognosis in patients treated with balloon coronary angioplasty, EUR HEART J, 21(21), 2000, pp. 1790-1796
Authors:
Takagi, S
Miyazaki, S
Fujii, T
Daikoku, S
Sutani, Y
Morii, I
Yasuda, S
Goto, Y
Nonogi, H
Citation: S. Takagi et al., Dexamethasone-induced cardiogenic shock rescued by percutaneous cardiopulmonary support (PCPS) in a patient with pheochromocytoma, JPN CIRC J, 64(10), 2000, pp. 785-788